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Abstract 
Several benzo[c]phenanthridine and protoberberine alkaloids, such as nitidine and berberrubine, are 
known to induce DNA cleavage in the presence of either topoisomerase I or II. Structure–activity 
studies performed on various analogues related to benzo[c]phenanthridine and protoberberine 
alkaloids have provided insights into structural features that influence this topoisomerase-targeting 
activity. Modifications within the A-ring of benzo[c]phenanthridine and protoberberine alkaloids can 
significantly alter their ability to enhance the cleavable complex formation that occurs between DNA 
and topoisomerases. Select benzo[i]phenanthridines were synthesized as potential bioisosteres of 
nitidine and its analogues. In the present study, 2,3-methylenedioxy-8,9-
dimethoxybenzo[i]phenanthridine, 2,3-methylenedioxy-8,9-dimethoxy-5-methylbenzo[i]phenanthridine, 
2,3,8,9-tetramethoxybenzo[i]phenanthridine and 5-methyl-2,3,8,9-tetramethoxybenzo[i]phenanthridine 
were synthesized. These benzo[i]phenanthridine derivatives were evaluated for their ability to 
enhance cleavable complex formation in the presence of topoisomerases and DNA as well as for their 
cytotoxicity against the human lymphoblastoma cell line, RPMI8402. 2,3-Methylenedioxy-8,9-
dimethoxybenzo[i]phenanthridine (4a) and its 5-methyl derivative (4b) are active as topoisomerase I-
targeting agents. In contrast to nitidine, the presence of the 5-methyl substituent in the case of 4b is 
not associated with enhanced activity. Consistent with previous structure–activity studies on nitidine 
and protoberberine alkaloids, 2,3,8,9-teramethoxybenzo[i]phenanthridine, 5a, and its 5-methyl 
derivative,5b, are inactive as topoisomerase I-targeting agents. These studies were extended to an 
evaluation of the relative pharmacological activities of 2,8,9-trimethoxybenzo[i]phenanthridine, 3,8,9-
trimethoxybenzo[i]phenanthridine, and 2,3-methylenedioxy-8,9-
methylenedioxybenzo[i]phenanthridine. 
 
